Florida · Senate Bill 876 · 2025 Regular Session

Chimeric Antigen Receptor T-cell Therapy

SB 876 Sponsored by Lori Berman Died in committee

  1. Introduced Feb 19, 2025
  2. In committee Feb 28, 2025
  3. Passed the Senate  
  4. Passed the House  
  5. To the governor  
  6. Became law Jan 1, 2026

What it does

The legislature's own summary of the bill, or its official long title.

Chimeric Antigen Receptor T-cell Therapy ; Prohibiting health insurers and health maintenance organizations issuing, delivering, or renewing certain policies or contracts from refusing to contract with or denying coverage for certain providers of chimeric antigen receptor T-cell therapy, etc.

Every action

5 steps, oldest first, as the legislature records them.

  1. SenateFiled
  2. CommitteeReferred to Banking and Insurance; Judiciary; Rules · Senate Banking and Insurance
  3. SenateIntroduced
  4. SenateIndefinitely postponed and withdrawn from consideration
  5. CommitteeDied in Banking and Insurance · Senate Banking and Insurance

Roll calls

No recorded votes on this bill yet.

Sponsors

The member who introduced it.

From Florida's official records (leg.state.fl.us; flhouse.gov), checked Nov 2, 2026. Text links go to the official versions; LegiList does not copy bill text.